Skip to main content

Table 2 Adolescent’s biochemical profile, according to BMI

From: Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional study

 

HW (n = 77)

OV (n = 82)

OB (n = 83)

P

TC, mg/dL

143 (32.1)

140 (34.3)

142 (39.8)

0.864

LDL-C, mg/dL

86 (33.5)

85 (35.6)

89 (40.1)

0.800

HDL-C, mg/dL

42 (13.5)

37 (13.3)*

35 (12.6)*

<0.001

TG, mg/dL

75 (29.7)

87 (49.7)

91 (45.1)*

0.07

TG/HDL-C

1.90 (0.86)

2.69 (1.98)*

3.07 (2.24)*

0.001

TC/HDL-C

3.67 (1.39)

4.02 (1.72)

4.59 (2.16)*

0.021

LDL-C/HDL-C

1.81 (0.52)

1.90 (0.90)

1.79 (0.71)

0.051

Non HDL-C

100.9 (33.9)

102.6 (38.3)

107.1 (43.2)

0,575

Apo AI, mg/dL

120.9 (18.0)

113.7 (19.6)

109.1 (21.2)*

0.001

Apo B, mg/dL

62.8 (10.6)

65.2 (15.8)

65.2 (17.5)

0.533

Apo B/Apo AI

0.53 (0.12)

0.60 (0.15)

0.61 (0.16)*

0.003

LDL-C/ApoB

1.38 (0.4)

1.33 (0.48)

1.37 (0.53)

0.810

HDL-C/ApoA

0.35 (0.09)

0.33 (0.12)

0.32 (0.10)

0.122

LDL (−), mg/mL

8.9 (5)

10.8 (4.9)

10.5 (5.2) *

0.042

Anti LDL(−), mg/mL

8.5 (2.6)

7.5 (2.7)*

7.2 (3.0)*

0.010

HDL size, nm

10.8 (2.7)

10.8 (2.3)

10.9 (3.2)

0.638

Glucose, mg/dL

79.3 (12.8)

78.0 (12.5)

82.0 (13.2)

0.130

Insulin, uU/mL

15.3 (7.1)

19.8 (8.2)*

25.9 (14.5)*;**

<0.001

HOMA-IR

3.0 (1.5)

3.9 (2.0)*

5.3 (3.1)*;**

<0.001

  1. HW, healthy weight; OV, overweight; OB, obese; BMI, Body Mass Index; WC, waist circumference, HOMA-IR, homeostasis model assessment of insulin resistance; TC, total cholesterol; LDL, low density lipoprotein; HDL, high density lipoprotein.
  2. Results were described as mean (standard deviation). *P < 0.05 vs HW group. **P < 0.05 vs OV group.